Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 13/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 12/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3964757 | 0.88 | HRH1 (0.45) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL12087476 | 0.83 | CYP3A4 (0.38) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL9054449 | 0.80 | CHRNA7 (0.42) | HRH1CYP2D6CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL3461681 | 0.78 | CHRNB2 (0.45) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| Ethane SCHEMBL29272596 | 0.77 | HRH1 (0.35) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL309452 | 0.76 | — | — | |
| SCHEMBL978915 | 0.76 | — | — | |
| SCHEMBL30390174 | 0.76 | — | — | |
| SCHEMBL28362525 | 0.75 | HSP90AA1 (0.40) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL20882979 | 0.74 | GAA (0.45) | HRH1CYP2D6KCNH2CHRM1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8330039-B2 | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-11 | — | — | US | disclosed |
| CN-102292826-A | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | — | 2011-12-21 | — | — | CN | disclosed |
| EP-2380208-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. du Pont de Nemours and Company (US) | 2011-10-26 | — | — | EP | disclosed |
| WO-2010085664-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-29 | — | — | WO | disclosed |
| US-20100180947-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-22 | — | — | US | disclosed |
| US-4188341-A | Process for the production of (substituted) 2,6-dimethylanilines | CIBA-GEIGY CORPORATION (US) | 1980-02-12 | — | — | US | disclosed |
| US-4183933-A | TREATMENT OF MENTAL ILLNESS, NEUROSIS, BEHAVIORAL DISTURBANCES, INFLAMMATION, ANOREXIA, AND CARDIAC AND VASCULAR DISORDERS | AB FERROSAN (SE) | 1980-01-15 | — | — | US | disclosed |